Diversity of vaginal microbiome and metabolome during genital infections Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

July 23, 2025

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-07-23

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This study aimed to investigate the vaginal microbiome and metabolome in women suffering from common genital infections such as vulvovaginal candidiasis (VVC), Chlamydia trachomatis (CT) infection, and bacterial vaginosis (BV). Using high-performance techniques like next-generation sequencing (NGS) and proton-based nuclear magnetic resonance (1H-NMR) spectroscopy, the researchers identified the bacterial community compositions and metabolite profiles across different conditions. The primary objective was to characterize the shifts in microbial and metabolic landscapes that occur during these infections and explore their potential implications in diagnosis and treatment.

Who was studied?

The study involved 79 reproductive-age women divided into four groups based on their clinical conditions: 21 healthy women (HC), 20 women with bacterial vaginosis (BV), 20 with C. trachomatis infection (CT), and 18 suffering from vulvovaginal candidiasis (VVC) due to Candida albicans. The study aimed to understand the microbial shifts between healthy and infected states by comparing these groups, which provided insights into microbial dysbiosis linked to these infections.

Most important findings

The study found that the vaginal microbiome in women with VVC and CT infections displayed significant shifts from the healthy state, with a decrease in Lactobacillus species, particularly L. crispatus, and an increase in various anaerobic genera such as Gardnerella, Prevotella, Megasphaera, Atopobium, and Roseburia. Notably, the VVC group showed increased glucose levels, which could promote the overgrowth of Candida species. The metabolic analysis revealed a decrease in lactate levels, a common marker of dysbiosis across these infections. The study further highlighted how these shifts in microbial communities correlated with significant changes in the vaginal metabolome, such as reduced lactate levels, indicating potential diagnostic markers for these infections.

Key implications

This study underscores the complexity of vaginal infections and their influence on both the microbiome and metabolome. The findings suggest that the depletion of Lactobacillus species, particularly L. crispatus, and the proliferation of anaerobic bacteria could serve as indicators of infection and microbial dysbiosis. The relationship between microbial changes and metabolic shifts, such as the reduction of lactate and the increase in glucose, opens new avenues for understanding the pathophysiology of these infections and for identifying novel biomarkers for diagnosis. These insights also suggest that therapeutic strategies aiming to restore a healthy vaginal microbiome could be beneficial in managing these conditions.

Vulvovaginal Candidiasis (VVC)

Vulvovaginal candidiasis (VVC) is a common fungal infection caused by Candida albicans. Disruptions in the vaginal microbiome and immune responses contribute to its development. Effective treatment involves both antifungal therapy and strategies to restore microbiome balance, preventing recurrent infections and addressing emerging antifungal resistance.

Bacterial Vaginosis

Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.